Product
IW-6463
3 clinical trials
2 indications
Indication
OtherIndication
MELASClinical trial
A Phase 1 Study Evaluating the Safety, Tolerability, Pharmacokinetics, Pharmacodynamics of IW-6463 When Administered to Healthy Volunteers as Single Ascending Doses, as Multiple Ascending Doses, and Under Fed Versus Fasting ConditionsStatus: Completed, Estimated PCD: 2019-10-22
Clinical trial
Evaluating the Safety, Tolerability, and Pharmacodynamic Properties of IW-6463 in Healthy Elderly SubjectsStatus: Terminated, Estimated PCD: 2020-05-22
Clinical trial
A Phase 2a Safety, Tolerability, Pharmacokinetic, and Pharmacodynamic Study in Individuals With Mitochondrial Encephalomyopathy, Lactic Acidosis, and Stroke-like Episodes (MELAS)Status: Terminated, Estimated PCD: 2022-01-23